Patents by Inventor Philip Fleshner

Philip Fleshner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF DIAGNOSING INFLAMMATORY BOWEL DISEASE THROUGH RNASET2
    Publication number: 20220162703
    Abstract: The present invention describes methods of diagnosing inflammatory bowel disease, including but not limited to Crohn's Disease (CD), Ulcerative Colitis (UC), and/or Medically Refractive Ulcerative Colitis (MR-UC), using RNASET2, TL1A and/or IFN-?. The invention further provides a process for patient identification and/or stratification.
    Type: Application
    Filed: October 28, 2021
    Publication date: May 26, 2022
    Inventors: Rebecca GONSKY, Stephan R. TARGAN, Richard L. DEEM, Philip FLESHNER, Dermot P. MCGOVERN, Janine BILSBOROUGH
  • Methods of diagnosing inflammatory bowel disease through RNASET2
    Patent number: 11186872
    Abstract: Described herein are methods of diagnosing inflammatory bowel disease, including but not limited to Crohn's Disease (CD), Ulcerative Colitis (UC), and/or Medically Refractive Ulcerative Colitis (MR-UC), using RNA-SET2, TL1A and/or IFN-Y. The methods may comprise treating inflammatory bowel disease by administering a therapeutically effective amount of a therapeutic agent to a subject. Described further herein are processes for patient identification and/or stratification.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: November 30, 2021
    Assignee: CEDARS-SINAI MEDICAL CENTER
    Inventors: Rebecca Gonsky, Stephan R. Targan, Richard L. Deem, Philip Fleshner, Dermot P. McGovern, Janine Bilsborough
  • METHODS OF DIAGNOSING INFLAMMATORY BOWEL DISEASE THROUGH RNASET2
    Publication number: 20190300957
    Abstract: The present invention describes methods of diagnosing inflammatory bowel disease, including but not limited to Crohn's Disease (CD), Ulcerative Colitis (UC), and/or Medically Refractive Ulcerative Colitis (MR-UC), using RNA-SET2, TL1A and/or IFN-?. The invention further provides a process for patient identification and/or stratification.
    Type: Application
    Filed: March 17, 2017
    Publication date: October 3, 2019
    Inventors: Rebecca GONSKY, Stephan R. TARGAN, Richard L. DEEM, Philip FLESHNER, Dermot P. MCGOVERN, Janine BILSBOROUGH
  • METHODS OF PREDICTING MEDICALLY REFRACTIVE ULCERATIVE COLITIS (mrUC) REQUIRING COLECTOMY
    Publication number: 20190218616
    Abstract: The present invention relates to methods of predicting the risk for colectomy in a subject with mrUC, by determining the presence or absence of one or more mrUC risk variants. Other embodiment, relate to methods of treating mrUC in a subject and a kit for prognostic use.
    Type: Application
    Filed: March 27, 2019
    Publication date: July 18, 2019
    Inventors: Jerome I. Rotter, Kent D. Taylor, Stephan R. Targan, Talin Haritunians, Dermot P. McGovern, Xiuqing Guo, Philip Fleshner
  • METHODS OF PREDICTING MEDICALLY REFRACTIVE ULCERATIVE COLITIS (mrUC) REQUIRING COLECTOMY
    Publication number: 20170044615
    Abstract: The present invention relates to methods of predicting the risk for colectomy in a subject with mrUC, by determining the presence or absence of one or more mrUC risk variants. Other embodiment, relate to methods of treating mrUC in a subject and a kit for prognostic use.
    Type: Application
    Filed: October 31, 2016
    Publication date: February 16, 2017
    Applicant: Cedars-Sinai Medical Center
    Inventors: Jerome I. Rotter, Kent D. Taylor, Stephan R. Targan, Talin Haritunians, Dermot P. McGovern, Xiuqing Guo, Philip Fleshner